Market for PACS and RIS is expected to grow, owing to factors such as developments in diagnostic imaging modalities coupled with the rising number of diagnostic tests procedures, affordable price of new generation PACS software and new product launches & FDA approvals. In addition, increasing demand for orthopaedic PACS likely to have a positive impact on the growth of the market in the coming years.
According to a new market research study titled ‘PACS and RIS Market to 2027 – Global Analysis and Forecasts by Product, Component, Deployment, and End User.’ The Global PACS and RIS Market is expected to reach US$ 5,008.93 Mn in 2027 from US$ 2,728.43 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027. The report highlights the trends prevalent in the global PACS and RIS market and the factors driving the market along with those that act as deterrents to its growth.
The market for PACS and RIS is expected to grow, owing to factors such as developments in diagnostic imaging modalities coupled with the rising number of diagnostic tests procedures, affordable price of new generation PACS software and new product launches & FDA approvals. In addition, increasing demand for orthopaedic PACS likely to have a positive impact on the growth of the market in the coming years.
Get Sample PDF Copy at https://www.theinsightpartners.com/sample/TIPRE00003005
Developments in Diagnostic Imaging Modalities Coupled with Rising Number of Diagnostic Tests Procedures
During the year 2012, Canadians underwent 1.7 million magnetic resonance imaging (MRI) exams and 4.4 million computed tomographies (CT) exams. The statistics reveal, nearly double the number of such reviews performed during 2003. The national rate for CT scans were 126 per 1,000 individuals around 2014 and 2015. Rates ranged from 209 (New Brunswick) and 170 (Newfoundland and Labrador) to 88 (Alberta) and 93 (Prince Edward Island). In addition, according to the National Health Services (NHS) UK, there were 4.1 million imaging tests conducted in England in the 12 months from February 2016 to January 2017. Of these, 3.49 million imaging tests were reported to have taken place in January 2017.
As per the World Health Organization (WHO), with improved health care policy and the better availability of medical equipment, there has been rise in the number of global imaging-based procedures. Thus, the growing number of diagnostic imaging procedures performed across the globe resulting in increasing requirement of consumables for tests are likely expected to drive the growth of the global PACS and RIS market over the coming years.
New Product Launches & FDA Approvals
Frequent FDA approvals and product launches drive the market for PACS and RIS. Most of the major market players operating in the market are adopting measures such as product launches as well as approvals to provide a better solution as well as software in the PACS and RIS market. For instance, during February 2019, Philips introduced IntelliSpace Cardiovascular 4.1, a cardiovascular image and information management system. The platform offers efficient pediatric reporting capabilities. With the rising prevalence of cardiovascular disorders, the launch of software can enable better treatment as well as diagnosis of these disorders.
Also, in June 2017, FDA approved IntelliSpace Portal 9.0 provided by Philips to be commercialized in the U.S. The system offers more than 70 applications in the field of radiology, such as oncology cardiology, and neurology. The platform provides clinicians a better overview of every patient, helping in quick diagnosis with the help of multimodality clinical applications developed for evaluation of patient data. The excellent benefits provided by these newly approved as well as launched products are expected to drive the demand for the market during the forecast period.
Buy Complete Report at https://www.theinsightpartners.com/buy/TIPRE00003005
Company Name: The Insight Partners
Contact Person: Sam J
Email: Send Email